Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. Mitchell, A. P., Winn, A. N., & Dusetzina, S. B. JAMA internal medicine, 178(6):854–856, 2018.
doi  bibtex   
@article{mitchell_pharmaceutical_2018,
	title = {Pharmaceutical {Industry} {Payments} and {Oncologists}' {Selection} of {Targeted} {Cancer} {Therapies} in {Medicare} {Beneficiaries}},
	volume = {178},
	issn = {2168-6114},
	doi = {10.1001/jamainternmed.2018.0776},
	language = {eng},
	number = {6},
	journal = {JAMA internal medicine},
	author = {Mitchell, Aaron P. and Winn, Aaron N. and Dusetzina, Stacie B.},
	year = {2018},
	pmid = {29630687},
	pmcid = {PMC6145757},
	keywords = {8 Ignorance and funding bias, Antineoplastic Agents, Biais de financement, Conflict of Interest, Drug Industry, Humans, Medicare, PRINTED (Fonds papier), Practice Patterns, Physicians', United States},
	pages = {854--856},
}

Downloads: 0